#Remdesivir
'Maybe he's just being philosophical'. Ok, that is mighty charitable. So was he being philosophical when he said ventilators and remdesivir killed people with COVID? When he said remdesivir killed people with Ebola?
February 21, 2025 at 11:04 PM
📢 Our paper is published in Oxford Open Immunology:

The ERASE_LC trial evaluated whether a 5-day course of intravenous remdesivir is feasible, safe, and acceptable for people living with Long COVID.

This is the first study to specifically examine remdesivir as a treatment for LC.
September 22, 2026 at 8:41 AM
🚀 The key message: ERASE-LC shows that administering IV remdesivir to people with LC is feasible, acceptable, and well tolerated. Signals suggest therapeutic promise, but only a properly powered RCT will determine whether remdesivir provides meaningful benefit.
September 22, 2026 at 8:41 AM
Glad to see this effort. Really, really hope they consider trying remdesivir + Paxlovid combination in a placebo trial. There are dozens of case studies documenting chronic infections cleared through treatment, most w/remdesivir + Paxlovid.

Crazy that we're still stuck on the idea of monotherapy.
📢 Our paper is published in Oxford Open Immunology:

The ERASE_LC trial evaluated whether a 5-day course of intravenous remdesivir is feasible, safe, and acceptable for people living with Long COVID.

This is the first study to specifically examine remdesivir as a treatment for LC.
September 22, 2026 at 9:48 AM
Donald Trump is only alive today because of aggresive supplemental oxygen treatments, remdesivir, monoclonal antibody therapy, and dexamethasone. You would think he would be a little more supportive of science.
August 25, 2026 at 6:48 PM
This is what 1065 dollars of Chinese black market remdesivir looks like
August 29, 2023 at 6:07 PM
C’est le genre de réactions qui font plaisir en confirmant ma décision de quitter twitter 😅

(Surgisphere, remdesivir, pangolin, je vous confirme ils ont été cryogénisés en 2020 !)
December 7, 2024 at 7:35 AM
In immunocompromised patients, persistent COVID often fails single-drug treatment.

Madrid study shows combination therapy (Remdesivir + Paxlovid ± Sotrovimab) clears infection and overcomes resistance. buff.ly/tqlmc0I

Personalized antiviral strategies matter.

#medsky #IDsky #publichealth #oncsky
February 14, 2026 at 10:45 PM
"significant survival benefit among patients hospitalized for SARS-CoV-2 infection receiving Remdesivir across all disease severity levels"

Systematic review & meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 infection in hospitalized patients: academic.oup.com/cid/article/...
A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 infection in hospitalized patients: have the guidelines evolved with the evidence?
AbstractBackground. With progressive accumulation of knowledge on SARS-CoV-2 infection clinical management, treatment guidelines recommended several option
academic.oup.com
March 15, 2025 at 5:49 PM
At Walter Reed, Trump begins taking the antiviral drug remdesivir. His blood oxygen dangerously low, he is also receiving dexamethasone, a steroid given to the most critically ill patients.
Notably, he is not treated with hydroxychloroquine or ivermectin, the quack cures he urged on his fans.
October 3, 2024 at 4:07 AM
IV Remdesivir feasibility study.
📢 Our paper is published in Oxford Open Immunology:

The ERASE_LC trial evaluated whether a 5-day course of intravenous remdesivir is feasible, safe, and acceptable for people living with Long COVID.

This is the first study to specifically examine remdesivir as a treatment for LC.
September 22, 2026 at 11:05 AM
Jimmy Dore claims that the people who died from COVID-19 actually died from intubation and Remdesivir, and he says they would've lived if they were given Ivermectin and Hydroxychloroquine.
October 15, 2025 at 2:43 AM
Remdesivir for COVID-19 linked to better outcomes for adult kidney transplant recipients medicalxpress.com/news/2026-07...
Remdesivir for COVID-19 linked to better outcomes for adult kidney transplant recipients
Adults with kidney transplants who were treated for COVID-19 with the antiviral remdesivir within a week of a COVID-19 diagnosis and who received at least three consecutive days of therapy were less l...
medicalxpress.com
July 29, 2026 at 5:04 AM
Sorry for the silence:

The ERASE-LC trial is making steady progress. All participants have now received their infusions of remdesivir and completed their post-treatment testing.
October 20, 2025 at 7:53 AM
Some perspective: I got Covid 2-weeks after completing my 12th round of chemo, on a plane flight wearing a N95 mask. My immune system was totally compromised. While I ended up in the hospital on Remdesivir for 5-days, I still believe that Moderna shot saved my life.
August 10, 2025 at 7:24 AM
In CID: Our real world study is the 1st (to our knowledge) to detail widespread restriction of remdesivir with patients that represent present-day epidemiology in the era of near universal SARS-CoV-2 seropositivity.

#IDSky
#MedSky
@ebhirsch.bsky.social

academic.oup.com/cid/advance-...
Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 Seropositivity
AbstractBackground. There is limited data to support routine remdesivir use in the contemporary era of SARS-CoV-2 with widespread seropositivity.Methods. A
academic.oup.com
April 26, 2025 at 3:12 PM
A review/meta-analysis "in The BMJ evaluated 40 treatments across 187 randomized trials involving more than 166,000 participants. Only two antivirals, nirmatrelvir-ritonavir (Paxlovid) and remdesivir, were found to moderately reduce the risk for hospitalization."

www.medscape.com/viewarticle/...
Most COVID-19 Drugs Fall Short, Meta-Analysis Confirms
A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to-moderate COVID-19 with moderate certainty.
www.medscape.com
July 14, 2025 at 2:58 AM
Antiviral drug remdesivir may cut risk of death in adults with severe COVID and kidney or liver disease

Risk was about 25% lower ⬇️ with early initiation in infected patients with either chronic disease who received supplemental oxygen.

Read more: https://bit.ly/46zvHYz
September 1, 2026 at 9:12 PM
🔬 We recruited 73 adults with confirmed Long COVID across two UK sites.

Key feasibility findings:
✅ 97% completed the full 5-day remdesivir course
✅ 96% completed follow-up assessments
✅ High engagement with outcome measures and symptom tracking
September 22, 2026 at 8:41 AM
I’ve accrued 5k+ followers this week and I’m humbled. Love you all.
This is my beautiful mum, who died of hospital acquired Covid in 2022. It’s nice to not get a slew of ‘she was sick anyway/gonna die soon/how fat was she/Remdesivir killed her’ comments.
November 17, 2024 at 6:32 PM
Ron Johnson AGAIN on remdesivir, "experimental gene therapy", hydroxychloroquine. Aren't you bored? I am.

▫️44/ #faucihearing
July 29, 2026 at 3:13 PM
One time when things were even worse during the past few years of this ::gestures around:: a patient’s family member put their finger on my chest and said “you better not kill him with your remdesivir!” and I had to explain that I was actually treating their relative for complications from diabetes.
December 23, 2024 at 5:24 AM
A meta-analysis of the 28 randomized trials assessing treatments for severe Covid nature.com/articles/s41... Data for IL-6 blockade (tocilizumab), baricitinib, remdesivir, and other drug interventions summarized
October 11, 2023 at 4:27 PM
From the UK

An Open-Label Feasibility Study of Remdesivir in Long COVID: Results from the ERASE LC Trial

dx.doi.org/10.1093/oxfi...

Screenshot from latest Science for ME weekly update

#LongCovid #PASC #PwLC #postcovid #postcovid19
October 1, 2026 at 12:34 AM
Rand Paul is an “ophthalmologist,” certified by a board that he created.

He's not a virologist.

His wife invested in Remdesivir at the peak of Covid as he pushed the drug on Americans. They didn't disclose their investment for 16 months.

They made a fortune.

Always the $.

shorturl.at/G5LW7
August 1, 2026 at 12:53 AM